140 related articles for article (PubMed ID: 420037)
1. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
[TBL] [Abstract][Full Text] [Related]
2. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced growth hormone and prolactin responses in schizophrenia research.
Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
[TBL] [Abstract][Full Text] [Related]
4. Effect of lithium on hypothalamic-pituitary dopaminergic function.
Lal S; Nair NP; Guyda H
Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
[TBL] [Abstract][Full Text] [Related]
5. CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
Nair NP; Lal S; Thavundayil JX; Wood PL; Etienne P; Guyda H
Neuropeptides; 1984 Jun; 4(4):281-91. PubMed ID: 6472582
[TBL] [Abstract][Full Text] [Related]
6. Effect of choline on central dopaminergic function in normal subjects.
Lal S; Etienne P; Thavundayil J; Nair NP; Collier B; Rastogi R; Guyda H; Schwartz G
J Neural Transm; 1981; 50(1):29-37. PubMed ID: 7205247
[TBL] [Abstract][Full Text] [Related]
7. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
[TBL] [Abstract][Full Text] [Related]
8. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
[TBL] [Abstract][Full Text] [Related]
10. Hormones, dopamine receptors and schizophrenia.
Meltzer HY; Busch D; Fang VS
Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
[No Abstract] [Full Text] [Related]
11. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
[TBL] [Abstract][Full Text] [Related]
12. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
[TBL] [Abstract][Full Text] [Related]
13. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
Lal S; Young SN; Cervantes P; Guyda H
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):331-5. PubMed ID: 7208604
[TBL] [Abstract][Full Text] [Related]
14. Effect of some peptides on dopaminergic function in man.
Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
[TBL] [Abstract][Full Text] [Related]
15. Naloxone inhibits prolactin and growth hormone release induced by intracellular glucopenia in the rats.
Okajima T; Motomatsu T; Kato K; Ibayashi H
Life Sci; 1980 Sep; 27(9):755-60. PubMed ID: 7412502
[No Abstract] [Full Text] [Related]
16. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
Nair NP; Lal S; Eugenio H; Lizondo E; Thavundayil JX; Wood PL; Etienne P; Guyda H
Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
[TBL] [Abstract][Full Text] [Related]
17. Failure of naloxone to reverse apomorphine effects in humans.
Rowbotham MC; Joseph MS; Jones RT; Keil LC
Psychoneuroendocrinology; 1983; 8(1):95-102. PubMed ID: 6308702
[TBL] [Abstract][Full Text] [Related]
18. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
Gorewit RC
Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
[No Abstract] [Full Text] [Related]
19. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
[TBL] [Abstract][Full Text] [Related]
20. Effect of sleep deprivation on dopamine receptor function in normal subjects.
Lal S; Thavundayil J; Nair NP; Etienne P; Rastogi R; Schwartz G; Pulman J; Guyda H
J Neural Transm; 1981; 50(1):39-45. PubMed ID: 7205248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
